Literature DB >> 10079437

Reticulated hyaluronic acid implant in nonperforating trabecular surgery.

P Sourdille1, P Y Santiago, F Villain, M Yamamichi, H Tahi, J M Parel, Y Ducournau.   

Abstract

PURPOSE: To evaluate experimentally and clinically the tolerance and efficacy of a reticulated hyaluronic acid implant in nonperforating trabecular surgery (NPTS).
SETTING: Bascom Palmer Eye Institute, Miami, Florida, USA, and Clinique Sourdille and Clinique Ophtalmologique Universitaire, Nantes, France.
METHODS: In experimental surgery, NPTS was performed with and without a hyaluronic acid implant in 25 rabbit eyes. In a pilot study, the results of NPTS with a hyaluronic acid implant in 72 human eyes were retrospectively analyzed in terms of visual acuity, intraocular pressure (IOP), external filtration, postoperative inflammation, and gonioscopy. Mean follow-up was 13.8 months (range 6 to 24 months).
RESULTS: In the experimental surgery, the rabbit eyes with the implant showed a different healing process than the eyes without the implant. The implant was slowly bioabsorbed and remnants were seen at the operative site (where the tissue was removed) up to day 56 postoperatively. This site was detectable at all histology study periods. Intraocular pressure reduction was longer in the implant group: greater than 5 months versus 3 weeks (P < .05). In the pilot study, visual acuity remained stable, IOP decreased from a mean preoperative level of 26.3 mm Hg +/- 5.22 (SD) to a mean postoperative level without treatment of 15.4 +/- 3.1 mm Hg (P < .0001). No external filtration was detected in 60 eyes, a slightly elevated conjunctiva was noted in 12 eyes. Postoperative inflammation (laser flare and cell measurements) was low. Gonioscopy consistently demonstrated the persistence of a decompression space behind the trabeculum.
CONCLUSION: Comparative experimental surgery results showed excellent tolerance and efficacy in the rabbit eyes with a hyaluronic acid implant. Clinical results, to be confirmed by a randomized comparative study, also showed excellent biocompatibility and encouraging efficacy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079437     DOI: 10.1016/s0886-3350(99)80080-7

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  18 in total

Review 1.  Non-penetrating glaucoma surgery: the state of play.

Authors:  J C Tan; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  A prospective randomised trial of viscocanalostomy with and without implantation of a reticulated hyaluronic acid implant (SKGEL) in open angle glaucoma.

Authors:  C Lüke; T S Dietlein; P C Jacobi; W Konen; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma.

Authors:  I I K Ahmed; C Kranemann
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

4.  [Canaloplasty. A new way in glaucoma surgery?].

Authors:  N Körber
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

5.  Retrobulbar hemodynamics and corneal surface temperature in glaucoma surgery.

Authors:  Fernando Galassi; Barbara Giambene; Andrea Corvi; Giacomo Falaschi; Ugo Menchini
Journal:  Int Ophthalmol       Date:  2007-10-19       Impact factor: 2.031

6.  Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss.

Authors:  H Ates; K Andac; O Uretmen
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

7.  A modified deep sclerectomy with or without external trabeculectomy: a comparative study.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-06-24

8.  Results of a modified non-penetrating deep sclerectomy in the treatment of open angle glaucoma with or without cataract.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-07-30

Review 9.  Modern concepts in antiglaucomatous implant surgery.

Authors:  T S Dietlein; J Jordan; C Lueke; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-06       Impact factor: 3.117

10.  SKGEL® implant versus T-Flux® implant in the contralateral eye in deep sclerectomy with phacoemulsification: long-term follow-up.

Authors:  Frank Schreyger; Gabor Scharioth; Holger Baatz
Journal:  Open Ophthalmol J       Date:  2008-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.